Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Cloudflare Inc (NET) Price & Performance

Iovance Biotherapeutics Inc. Common StockTrade
Cloudflare IncTrade

Price performance (Past 24H)

Key statistics

Iovance Biotherapeutics Inc. Common Stock vs Cloudflare Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.43 (market cap $6.04B), while Cloudflare Inc trades at $347.58 (market cap $121.74B). The key difference: Cloudflare Inc is far larger — about 20.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 2,433,002). Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Cloudflare Inc for 61 Days on average.

IOVANET
Market Cap
$6.04B$121.74B
Volume
14,805,9932,433,002
Sector
HealthTechnology
52-Week High
$14.82$359.60
52-Week Low
$1.81$160.16
Typical Hold Time
0 Days61 Days
Enterprise Value
$5.97B$121.11B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Cloudflare Inc

Cloudflare (NET) trades at $342.82, down 3.44% on the day, as the stock consolidates near recent highs. The company continues to demonstrate strong revenue growth with $2.17 billion in 2025 sales, though profitability remains challenged with a -8.21% net margin. Recent technical indicators show a bullish trend with the stock trading above key support levels, while analyst sentiment remains overwhelmingly positive with 71% buy ratings. The company's recent product launches including Cloudflare Basin and strategic partnerships with Deutsche Telekom highlight ongoing innovation in the connectivity cloud space.

Cloudflare presents a growth story with expanding enterprise adoption but faces valuation concerns at current levels. The stock's premium multiples (P/S 47.88) require continued execution against strong revenue growth targets. Key risks include persistent profitability challenges and competitive pressures in the cloud security market, while catalysts include AI-driven security demand and platform consolidation opportunities.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IOVA
100% Buy0% Sell
Avg holding period · 0 Days
NET
61% Buy39% Sell
Avg holding period · 61 Days

Top news

Latest headlines on both assets

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →

About Cloudflare Inc

Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.

Read more on NET →